Tuberculosis in Immunocompromised Patients
Versandkostenfrei!
Versandfertig in 6-10 Tagen
24,99 €
inkl. MwSt.
PAYBACK Punkte
12 °P sammeln!
Tuberculosis (TB) and HIV co-infections have a global prevalence with high morbidity and mortality and Africa is the worst hit. The HIV and AIDS has profound impact on the TB epidemic in Kenya, where up to 60% of TB patients are likely to be HIV co-infected and the mortality rate attributed to TB. Lack of diagnostic capacity has been a major barrier preventing an effective management of HIV-associated and drug resistant tuberculosis (TB). Although many books have been written on Tuberculosis, few have attempted to provide a detail overview of Tuberculosis in Immunocompromised patients. This is...
Tuberculosis (TB) and HIV co-infections have a global prevalence with high morbidity and mortality and Africa is the worst hit. The HIV and AIDS has profound impact on the TB epidemic in Kenya, where up to 60% of TB patients are likely to be HIV co-infected and the mortality rate attributed to TB. Lack of diagnostic capacity has been a major barrier preventing an effective management of HIV-associated and drug resistant tuberculosis (TB). Although many books have been written on Tuberculosis, few have attempted to provide a detail overview of Tuberculosis in Immunocompromised patients. This is the only single source, comprehensive coverage on Tuberculosis in Immunocompromised Patients. This book emphasizes on both basic science and clinical science aspects. This book is intended for researcher in the field of Tuberculosis, clinicians, diagnostic laboratory technicians, undergraduate, graduate and medical students.
Andere Kunden interessierten sich für
